Max Narovlyansky

Max Narovlyansky is an accomplished professional in the fields of biochemistry and biotechnology, currently serving as the Chief Executive Officer at Sanus Galt Inc since November 2023, where the focus is on personalized medicine and fintech innovations in medical data. Narovlyansky also holds the position of Senior Scientist at Xheme, working on solutions to reduce oxidative stress in bioprocessing. Previously, Narovlyansky founded FlowCell, a marketplace for precision medicine tools and services, and served in various scientific leadership roles, including Director of Assay Development at Eutropics Pharmaceuticals and Principal Scientist at Instrumentation Laboratory. Narovlyansky's academic credentials include a Ph.D. in Biochemistry from Harvard University and a B.S. in Chemistry from Caltech.